Outsourcing

Pharmaceutical Outsourcing Present and Future

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Navigating the Preclinical CRO Outsourcing Process

The need for preclinical testing expertise is growing as molecular complexity increases.

A Closer Look at Affinity Ligands

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

Demystifying Complex Clinical Trial Kit Preparation

February 01, 2021

Best practices can help ensure supply chain flexibility and viability for biologic drugs in clinical trials.

Contract Service Tapped to Produce COVID-19 Vaccines

February 01, 2021

Contract development and manufacturing organizations provide vital services to rush COVID-19 vaccines to patients.

Is Collaboration the Key to Accelerating Biotherapeutic Development?

January 05, 2021

Vendors are finding ways to address the increasingly complex analytical challenges in the biopharmaceutical industry to further biotherapeutic development.

Bringing Bio/Pharma’s “New Normal” Into Focus

January 03, 2021

Biopharma looks to deliver on COVID-19 vaccines and other promising therapies.

Compensation Does Not Necessarily Align With Job Satisfaction

January 03, 2021

Essential bio/pharma employees show hard work and dedication can pay off for patients.

Overcoming Biologic Drug Formulation Hurdles

January 03, 2021

The right partner can help companies overcome key formulation challenges for biologic drugs.

Meeting Specificity Needs for Biologic Drug Substance Testing

January 02, 2021

Traditional biologic-based testing methods may need an upgrade to properly test newer therapeutic modalities.

Supporting the Industry During a Pandemic

January 02, 2021

Outsourcing increases as the industry balances development and manufacturing of both COVID-19 treatments and non-pandemic-related medicines.

Aceto Acquires IsleChem

December 23, 2020

The virtual manufacturer and distributor of specialty materials acquired the NY-based company, adding analytical and manufacturing expertise.

Sygnature Discovery Expands High-Throughput Screening and Translational Oncology

December 23, 2020

The UK company is investing £3 million in new instrumentation and equipment to strengthen its high-throughput screening and translational oncology service offerings.